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Abstract 
 
Background 
Smoking and excess body weight are major preventable risk factors for premature death. This study 
aimed at analysing their single and combined association with site-specific cancer mortality. 
Methods 
Our study population comprised 35,784 men and women aged 14-99 years, who participated in 
population-based health surveys conducted 1977-1993 in Switzerland and were followed-up for 
mortality until 2008. Multivariable Cox proportional hazards models were calculated for different 
cancer sites, and population attributable fractions were derived. 
Results 
The hazard ratio of dying from cancer (all sites) was 2.32 [95% CI: 2.04, 2.63] for heavy smokers (vs. 
never smokers) and 1.15 [1.01, 1.32] for obese (body mass index (BMI) ≥ 30 kg/m2) vs. normal 
weight individuals. Heavy smoking (≥ 20 cigarettes/day) was associated with increased mortality due 
to cancer of the lung, upper aero-digestive tract, pancreas, bladder, liver, and the total of remaining 
sites. Obesity was associated with higher risk of dying from cancer of the liver and the female genital 
tract (essentially corpus or cervix uteri and ovary). More than 20% of all cancer deaths in our 
population were attributable to ever smoking and overweight (BMI ≥ 25 kg/m2).  
Conclusions 
Smoking was a much stronger risk factor for cancer than excess body weight. For lung, liver and 
pancreatic cancer the combination of excess body weight and smoking lead to cumulated higher 
risks.  
Impact 
Our findings support recommendations for obese persons to quit smoking despite potential post-
cessation weight gain. 
 
Abbreviations: 
BMI: body mass index 
NRP 1A: National Research Program 1A 
SOMIPOPS: SOcio-Medical Indicators for the POPulation of Switzerland 
MONICA: MONItoring of trends and determinants in CArdiovascular disease 
SHS: Swiss Health Survey 
CI: confidence interval 
SNC: Swiss National Cohort 
UADT: upper aero-digestive tract 
ICD: International Classification of Diseases 
HR: hazard ratio 
AIC: Akaike’s information criterion 
PAF: population attributable fraction 
SD: standard deviation 
PA: physical activity 
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Introduction 
 
In Switzerland, as in other developed countries, age-standardized mortality due to cancer is 
declining, however less than that due to other causes of death. As a consequence of population 
ageing, case counts are still increasing. Even more unfavorable are the figures for cancer incidence 
(1), underlining the importance of prevention. Smoking and obesity are two major risk factors for 
premature death in western populations (2–4). Their prevalence is still high in many countries. While 
smoking has slowly decreased over the past decades (particularly in men), it is unclear whether the 
obesity epidemic has reached its peak (5). In Switzerland, recent trends suggest a continuation of the 
increase of the obesity prevalence over time in adults (6). Individuals, who accumulate these two risk 
factors, i.e. smoking plus obesity, may have a particularly high risk of dying from cancer. Statistics 
from 2012 indicate that of the adult male and female permanent resident population of Switzerland, 
49% and 29% had excess body weight (body mass index (BMI) ≥ 25 kg/m2), 29% and 22% smoked, 
and 13% and 6% had excess body weight and smoked, respectively (7).  
The few studies looking at this co-occurrence provided, however, conflicting results (2,8,9). 
Freedman et al. (2) reported the cancer mortality risk to be higher in obese than in normal weight 
current smokers, but for older individuals (age ≥ 65 years) the association between obesity and 
cancer mortality was more apparent in never than in former or current smokers. In contrast, Kitsantas 
et al. (8) reported that younger women (41-50 years) who smoked had a higher cancer mortality risk 
if they were underweight. Hjellvik (9) et al. examined middle age death risk and observed the 
combination of obesity and heavy smoking to increase the risk by the factor of 5.  
Moreover, it is unclear whether specific cancer sites are more affected than others by smoking, 
obesity or both, and which BMI levels, i.e., overweight and obesity vs. normal weight, are important.  
Our aim was to examine the significance of smoking and increased BMI on overall and site-specific 
cancer mortality in terms of relative risks and population attributable fractions (PAF). For this 
purpose, we used data from general population-based studies conducted in Switzerland between 
1977 and 1993, which were linked with the Swiss National Cohort (SNC) for a mortality follow-up until 
the end of 2008. 
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Materials and Methods 
 
Study population 
Details about the study population were described previously (10). In brief, it consists of 35,784 
participants aged 14-99 years at baseline who participated in one of four different population-based 
studies conducted between 1977 and 1993: NRP 1A (National Research Program 1A, 1977-79), 
SOMIPOPS (SOcio-Medical Indicators for the POPulation of Switzerland, 1982), Swiss MONICA 
(MONItoring of trends and determinants in CArdiovascular disease, three waves: I, 1984-86; II, 
1988/89; III, 1992/93), and the first SHS (Swiss Health Survey, 1992/93). Cause-specific mortality 
follow-up until 2008 was obtained via anonymous record linkage with the Swiss National Cohort 
(SNC) (10,11).  
After exclusion of 81 participants because of missing values in covariates used for the fully adjusted 
model, our study population comprised 35,703 participants with a mean and maximum follow-up time 
of 18.9 and 31.9 years, respectively. More details about the study population stratified by survey can 
be found in Supplementary Table S1. 
 
Body Mass Index (BMI) 
BMI was defined as weight (kg) divided by the square of height (m2) and classified into following 
categories: normal/underweight (reference category, BMI < 25.0 kg/m2), overweight (25.0 ≤ BMI < 
30.0 kg/m2), and obesity (BMI ≥ 30.0 kg/m2). Only about 3.5% of the study population was 
underweight (BMI < 18.5 kg/m2). Moreover, this underweight population (irrespective of smoking 
status) had a similar cancer risk as normal weight persons (10). We therefore combined this category 
with normal weight in our analyses. In MONICA and NRP 1A, weight and height were measured at 
baseline, whereas in SOMIPOPS and SHS 92/93, they were reported by the participants (10).  
 
Smoking 
We defined the following smoking categories: never (reference category), former (reported having 
ever smoked for more than 6 months), current light (< 20 cigarette equivalents a day) and current 
heavy (≥ 20) smokers. Thereby, one pipe or cigarillo equals two, and one cigar equals four cigarette 
equivalents. Unfortunately, we only had fragmentary information on smoking duration and intensity in 
former smokers.   
 
Covariates  
Besides the covariates smoking and BMI we chose age (in years), sex (where appropriate), survey, 
years of education, marital status, nationality, frequency of physical activity (PA), alcohol 
consumption and a diet proxy variable for the fully adjusted model. For all covariates we used 
baseline information.  
The covariate survey had 6 categories: NRP 1A, SOMIPOPS, MONICA I-III, SHS. Marital status had 
4 categories: single, married, widowed, divorced. Nationality was binary: Swiss and other 
nationalities. For frequency of PA we used the categories daily, several times per week, once per 
week, and less. Alcohol was used as a binary variable and refers to the consumption the day before 
the interview (yes/no). As a proxy for a healthy diet a binary variable was defined: For MONICA, NRP 
1A and SOMIPOPS as “regularly eating three main meals per day” and for SHS 92/93 as “eating 
fruits and vegetables at least once per day”.  
 
Outcome variables 
Causes of death were coded according to the International Classification of Diseases (ICD). Until the 
end of 1994 the 8th (ICD-8) and since 1995 the 10th (ICD-10) revision was used. For our cancer-
specific analyses we aggregated them in the following 13 cancer groups: all cancers (ICD-8: 140-
239; ICD-10: C00-C99; D00-D48), cancer of the lung (ICD-8: 162; ICD-10: C33-C34), colon or 
rectum (ICD-8: 153-154; ICD-10: C18-C21), upper aero-digestive tract (UADT, ICD-8: 140-150, 161; 
ICD-10: C0, C10-C15, C32), lymphatic and haematopoietic tissue (abbreviated as “blood cancer” in 
the following, ICD-8: 200-209; ICD-10: C81-C86, C88, C90-C96), pancreas (ICD-8: 157; ICD-10: 
C25), bladder (ICD-8: 188-189; ICD-10: C67-C68), liver (ICD-8: 155; ICD-10: C22), stomach (ICD-8: 
151; ICD-10: C16), breast (ICD-8: 174; ICD-10: C50), female genital tract (ICD-8: 180-184; ICD-10: 
C51-C58), prostate (ICD-8: 185; ICD-10: C61), and the total of remaining cancer sites. 
 
Statistical analysis 
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For descriptive analyses, we stratified the population by sex and smoking status and calculated 
counts, means, standard deviation, and proportions. To reduce the number of missing values, we 
imputed (12) the covariates BMI (number of missing values (n) = 451), years of education (n = 577) 
and frequency of physical activity (PA, n = 1,021). Multiple imputation was used for BMI and 
frequency of PA. As we had information on the education category (mandatory (modal value 9 
years), further education (12 years), higher education (16 years), university (19 years)) for most of 
the missing values in the variable “years of education”, we used the modal value (was the same for 
women and men in all categories) for each category as imputation value. For all analyses, we 
excluded 81 observations that after imputation still contained missing values for one of the covariates 
required for the fully adjusted model. 
To derive hazard ratios (HR) we calculated Cox proportional hazards models. We hereby used 
survival or censoring time from study entry as well as different cancer site-specific binary variables as 
outcomes. The models were calculated for both sexes separately and combined. Time to event or 
censoring was defined as time difference between study entry (date of baseline interview) and date 
of death from site-specific cancer, or the possible censoring dates of death from other causes, 
emigration, or end of the study (December 31, 2008), respectively. Model variables were selected 
according to Akaike’s information criterion (AIC). We calculated two Cox models for every cancer-
specific outcome with different adjustment levels: Beside smoking and BMI, the basic model was 
adjusted for age, sex (where appropriate), and survey. The multivariable adjusted model additionally 
included years of education, marital status, nationality, frequency of PA, alcohol consumption and 
healthy diet. We also tested for a multiplicative interaction effect of smoking with BMI in the models. 
In order to calculate cumulative HRs for different risk combinations of BMI and smoking categories, 
we used linear combinations of the estimated HRs from the Cox models. The proportional hazards 
assumption was tested using Schönfeld residuals. The assumption was sufficiently fulfilled for all sex-
specific models and not fulfilled for three out of ten sex-combined models, namely for all cancer 
deaths combined, lung cancer and the total of remaining cancer deaths.  
To calculate population attributable fractions (PAFs) for smoking and BMI we used the punafcc 
STATA package by Newson (13). Smoking (ever including former vs. never smoking) and BMI (cut-
off point at 25 kg/m2) were dichotomized for this analysis. This cut-off point for BMI was selected due 
to small case numbers for obese participants. 
All analyses were conducted in STATA 13 (StataCorp. 2013. Stata Statistical Software: Release 13. 
College Station, TX: StataCorp LP).
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Results 
 
Baseline characteristics and figures for specific cancer sites are shown in Table 1. Heavy smokers 
exhibited higher proportions of persons being physically inactive and following a poor diet than 
individuals of the other smoking categories. The proportion of those who reported alcohol 
consumption on the previous day was lower in never smokers compared to all others. The mean age 
at baseline was lower for light and heavy smokers than for never and former smokers. Mean BMI 
was highest for former smokers. Sex-specific values are shown in Supplementary Table S2. Of the 
7,383 persons who died in 676,312 person-years, 2,379 died of cancer. The proportion was higher in 
ever smokers (35.9%) than in never smokers (28.3%). This was mainly due to lung cancer and - to a 
smaller extent - to UADT cancer. In heavy smokers, about 41% and 10% of cancer deaths were from 
lung and UADT cancers as opposed to 8% and 3% in never smokers, respectively. On the other 
hand, deaths from other cancers, such as colorectal, were less frequent in heavy smokers compared 
to the other smoking categories. 
 
Table 2 shows HRs with 95% confidence intervals (CI) of BMI and smoking categories based on the 
fully adjusted Cox model for both sexes combined. Results from the basic model differed only 
marginally (data not shown). The risk for dying of any cancer was 15% [95%-CI: 1%-32%] higher for 
obese compared to normal-weight persons and 132% [104%-164%] higher for heavy compared to 
never smokers. Heavy smoking was also associated with an increased risk of dying from lung, 
UADT, pancreas, bladder, and liver cancer as well as a cancer of the remainder group. Former and 
light smoking were associated with increased risk to die of any site, lung and UADT cancer. 
Moreover, former smoking was associated with a higher risk for liver cancer. The significant 
association of former smoking with lung cancer (HR=2.29 [1.64, 3.20]) was only due to the 
association in men (HR=2.22 [1.46,3.38]; women: HR=1.05 [0.47, 2.34]). Sex-specific results of the 
fully adjusted model are shown in Supplementary Table S3. As a sensitivity analysis, we categorized 
smokers exclusively based on the number of cigarettes smoked per day (i.e. not considering cigars, 
cigarillos and pipes). The classification was the same for 96.4% and 97.8% of light and heavy 
smokers, respectively. The results of the Cox models remained virtually unchanged, with respect to 
both, the magnitude and the statistical significance.  
Obese participants had an elevated risk of dying from cancers of the liver and female genital tract 
compared to normal weight persons whereas in overweight individuals, only prostate cancer reached 
statistical significance. We did not detect a significant association of overweight or obesity with breast 
cancer mortality in our data when looking at the entire age span. Inclusion of a smoking BMI 
interaction term did not significantly improve our models for all 13 cancer sites. In a sensitivity 
analysis, we calculated the Cox models in participants with measured BMI (NRP1A, MONICA I-III). 
The associations with all sites combined and liver cancer mortality were very similar. However, the 
association between obesity and pancreas cancer was statistically significant (HR=2.37, 95% 
CI=[1.25, 4.48]) despite fewer mortality cases (77 vs. 127). 
 
As shown in Figure 1, there is a suggestive cumulative association of BMI and smoking with specific 
cancer sites, such as pancreas or liver. For the other cancer sites, there was no significant 
cumulative association seen. Exact figures for the cumulative HRs including 95% CIs are shown in 
the Supplementary Material in Table S4 for all specific cancer sites. 
 
The proportions of selected site-specific and total cancer deaths attributable to ever (including 
former) smoking and BMI ≥ 25 kg/m2 are shown in Figure 2. Exact values of the PAFs including 95% 
CIs, also for other relevant cancer sites and sex-specific, are shown in Supplementary Table S5. 
About 22% of prostate cancer deaths were attributable to BMI ≥ 25 kg/m2. For total, lung and liver 
cancer, 13%, 61% and 39% of deaths were attributable to ever smoking, respectively. Of all deaths 
deaths due to liver, pancreatic and prostate cancer 50%, 29% and 29% were attributable to ever 
smoking and overweight combined, respectively.
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Discussion 
 
Our results show that smoking was more strongly associated with cancer mortality than obesity. 
Heavy smokers had higher risks of dying from total, lung, UADT, pancreatic, bladder and liver cancer 
compared to never smokers. Moreover, former and light smokers had an increased risk of dying from 
any cancer, mainly due to lung and UADT cancer. Being obese compared to normal weight was 
associated with a small increased overall cancer risk and an elevated site-specific risk for cancer of 
the liver, the female genital tract as well as pancreatic cancer (only in participants with measured 
BMI). We did not observe a significant interaction between increased BMI and smoking on cancer 
mortality risk, which speaks against a substantial cumulative association with smoking and BMI. 
When calculating the PAF of ever smoking and overweight combined there was a suggestive 
cumulative assiciation with cancer mortality risk for some cancer sites. More than 20% of all cancer 
deaths, in particular about 50%, 29% and 29% of liver, pancreatic and prostate cancer mortality 
cases were attributable to ever smoking and excess weight (BMI ≥ 25 kg/m2), respectively. 
Based on previous reviews (14–17) on cancer incidence, regarding the sites analysed in this study, 
an association with smoking has been reported for lung, stomach, pancreatic, bladder, UADT, and 
liver cancer. In our analysis, we confirmed all these associations except for stomach cancer, which 
could be due to the relatively small number of cases (n=74). However, the results from the basic 
model showed a significantly increased stomach cancer risk in heavy smoking men (HR=2.69 [1.08, 
6.73], n=10). Based on the same reviews, for colorectal, breast and prostate cancer, an association 
with smoking is uncertain or unlikely. This is in line with our results. A more recent review, however, 
has shown that current smoking is related to progression in prostate cancer leading to more 
aggressive and fatal cases (18). For incidence and mortality of colorectal cancer smoking was 
reported to be a risk factor (14,19). In previous studies, an association with smoking was shown for 
myeloid but not for lymphatic leukaemia (15). We did not account for this difference in our analysis 
and did indeed not see an association with smoking on overall blood cancer risk. For cancer of the 
female genital tract, we did not detect any association with smoking. Our definition of this site is a mix 
of different female cancers. Others suggested that smoking has no association with ovarian (15), an 
inverse association with endometrial (15,20), and doubles the risk for cervical cancer (15). 
Concerning incidence, the following of the cancer sites analysed in our study were shown to be 
positively associated with obesity: colon, postmenopausal breast, adenocarcinoma of the esophagus 
(included in our definition of UADT cancer), endometrium, pancreas, advanced-stage prostate, and 
liver (21). For the remaining sites, evidence is conflicting. Accordingly, we observed an association of 
obesity with liver cancer and in participants with measured BMI values with pancreatic cancer. For 
prostate cancer, we observed a statistically significant association with overweight but not obesity. A 
possible explanation is the low power, as our population comprised only 23 obese prostate cancer 
deaths. In our data, obesity was also positively associated with death due to cancer of the female 
genital tract. In the Million Women Study (UK), an association between elevated BMI and endometrial 
as well as ovarian but not cervical cancer incidence was observed (22). In contrast to our results, in 
the same study, an association between obesity and leukaemia was reported. Again there are 
discordant definitions and also the power might have been too low (14 blood cancer deaths among 
obese women). For breast cancer, we did not detect an association with BMI. Because of lack of 
information, we were unable to accurately classify deaths by menopausal status. Again, probably due 
to lack of statistical power, we could not confirm the association of obesity with pancreatic cancer 
(n=19). Furthermore, this association appears to be generally weak (23). We did see, however, that 
the mean BMI in female and male cases was significantly about 1.9 and 1.3 BMI units higher, than in 
non-cases, respectively. Moreover, there may be a cumulative association of smoking plus excess 
body weight with pancreatic cancer mortality risk (Figures 1 and 2).  
Relatively few studies examined the interaction of these two cancer risk factors. Previous 
publications corroborate our findings of a stronger impact of smoking (vs. obesity) on cancer risk 
(2,3,8). This might be explained by residual confounding of unobserved lifestyle habits, as smokers 
tend to exhibit an unhealthier overall lifestyle (24,25). Besides, a lack of a general BMI-smoking 
interaction on mortality was reported previously (26,27). However, as suggested by our results, this 
joint association may depend on the respective cancer site. We could identify one study that also 
suggested a cumulative association of obesity and smoking with pancreatic cancer risk (28). In 
contrast to our results, Rauscher et al. (29) observed that obesity was associated with lung cancer 
risk in a non-smoking population. Furthermore, Luo et al. (30) observed that the association of 
smoking with breast cancer risk is modified by obesity in postmenopausal women, which was also 
not apparent in our population.  
	   8	  
 
Our study comprised a large general population sample with a follow-up time of up to 32 years. The 
data stem from Switzerland, a country with a highly developed health care system allowing secure 
diagnoses. Our data also included a wide range of lifestyle factors allowing to account for potential 
confounding. Another strength of our study is that we were able to calculate the impact of smoking 
and BMI on specific cancer sites. Our study has several limitations. Firstly, we had data only on 
cancer mortality and no information on cancer incidence. However, Reeves et al. reported that the 
relationship between BMI and cancer mortality was similar to that of cancer incidence in women (22). 
Secondly, we only had baseline information on smoking and BMI. In light of the long follow-up time, 
participants might have changed their behavior over time. Thirdly, the PAFs were calculated only on 
the basis of our baseline and mortality data, which stem from up to 39 years ago. Therefore, the 
results should be interpreted with caution, as the prevalence e.g. of tobacco use or lung cancer 
mortality rates changed over the years. Fourthly, the exposure measurement in our study was crude 
and, for some variables, not uniform as we pooled different samples to obtain a sufficient number of 
specific cancer cases. For example, BMI was partly measured and partly self-reported and the 
definitions for healthy diet were different. The different BMI measurements, however, should not have 
a substantial impact on the relative mortality risks as shown previously by our group (10). In this 
publication the same pooled dataset was used to analyze all-cause mortality and a sensitivity 
analysis using a mixed effects Cox model with random effects for survey was performed. The results 
of that sensitivity analysis showed that adjusting for survey sufficed. Accordingly, we adjusted for 
survey in all our Cox models to compensate for heterogeneity. Finally, our study population is 
presumably healthier than the general population, which might influence prevalence rates (31). 
However, in the same study there was no difference in cancer mortality risk between the MONICA 
sample and the general population detected. We would expect that this applies also to the other 
samples included in our study. 
 
Conclusion 
 
In Switzerland, 19.7% of fatal cancer were attributable to ever smoking. When adding overweight this 
proportion increased slightly to 20.6%. In this country, as in other developed nations, cancer as 
cause of death is gaining relative significance. Therefore, the government, public health authorities 
and primary care providers need to intensify their efforts aimed at reducing the modifiable proportion 
of cancer risk. Our results suggest that tobacco control is by far the most efficient measure to prevent 
cancer deaths. The overall impact of excess weight on cancer mortality risk was comparably small, 
which underlines the importance of recommendations for obese persons to quit smoking despite 
potential post-cessation weight gain.  
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Tables 
Table 1: Baseline characteristics of the study population and figures of cancer mortality for specific cancer sites 
stratified by smoking status. Sex-specific results can be found in Supplementary material Table S2. 
Smoking status never former light a Heavy b TOTAL 
n observations 16,786 6,426 7,320 5,171 35,703 
% observations 47.0 18.0 20.5 14.5 100 
n deaths from all causes 3,476 1,438 1,367 1,102 7,383 
% deaths from all causes c 20.7 22.4 18.7 21.3 100 
Person-years 319,345 115,414 144,589 96,961 676,309 
Mean (SD) follow-up in years 19.0 (7.3) 18.0 (7.0) 19.8 (7.6) 18.8 (7.3) 18.9 (7.3) 
Mean (SD) age in years 47.1 (16.7) 48.7 (14.8) 42.6 (14.7) 41.4 (12.2) 45.6 (15.6) 
Mean(SD) BMI in kg/m2 24.2 (4.0) 25.0 (3.9) 23.9 (3.8) 24.3 (3.8) 24.3 (3.9) 
BMI categories 
% BMI < 25 63.4 53.5 65.2 61.2 61.6 
% 25 ≤ BMI < 30 28.4 36.8 28.6 31.9 30.5 
% BMI ≥ 30 8.2 9.7 6.2 7.0 7.9 
Marital status 
% single 21.5 12.4 24.1 22.8 20.6 
% married 64.5 75.9 64.9 63.8 66.5 
% widowed 9.1 5.3 3.9 2.5 6.4 
% divorced 4.8 6.4 7.1 11.0 6.5 
Frequency of physical activity 
% daily 6.5 6.5 5.9 4.8 6.1 
% several times per week 22.5 25.3 22.6 17.8 22.4 
% once per week 22.1 21.4 22.9 17.8 21.5 
% less than once per week 48.9 46.8 48.6 59.6 50.0 
Other covariates 
Alcohol (% yes) 56.9 74.6 71.0 76.5 65.8 
Healthy diet d (% yes) 73.0 67.7 63.0 48.2 66.6 
Mean (SD) years of education 11.5 (3.2) 12.2 (3.2) 12.0 (3.2) 11.8 (3.1) 11.8 (3.2) 
Nationality (% Swiss) 85.1 83.7 81.6 79.0 83.2 
Cancer Mortality 
All cancer sites n 985 494 467 433 2,379 % e 28.3 34.4 34.2 39.3 32.2 
Lung cancer n 76 79 93 178 426 % f 7.7 16.0 19.9 41.1 17.9 
Colorectal cancer n 125 61 44 20 250 % f 12.7 12.3 9.4 4.6 10.5 
UADTcancer n 27 24 31 43 125 % f 2.7 4.9 6.6 9.9 5.3 
Blood cancer n 120 53 45 28 246 % f 12.2 10.7 9.6 6.5 10.3 
Pancreatic cancer n 56 28 26 17 127 % f 5.7 5.7 5.6 3.9 5.3 
Bladder cancer n 36 15 16 18 85 % f 3.7 3.0 3.4 4.2 3.6 
Liver cancer n 24 22 16 19 81 % f 2.4 4.5 3.4 4.4 3.4 
Stomach cancer n 37 19 8 10 74 % f 3.8 3.9 1.7 2.3 3.1 
Breast cancer g n 141 20 24 19 204 % f 14.3 4.1 5.1 4.4 8.6 
Cancer of female 
genitals g 
n 86 15 24 7 132 
% f 8.7 3.0 5.1 1.6 5.6 
Prostate cancer h n 49 57 52 12 170 % f 5.0 11.5 11.1 2.8 7.2 
Remaining cancer 
cases 
n 208 102 89 63 462 
% f 21.1 20.6 19.1 14.6 19.4 
a Current light smokers: smoking less than 20 cigarette equivalents a day. One pipe or cigarillo correspondents to two and 
one cigar to four cigarette equivalents.  
b Current heavy smokers: smoking at least 20 cigarette equivalents a day. 
c Percent of all observations in this smoking category.  
d Defined as follows: MONICA, NRP 1A and SOMIPOPS: regularly eating three main meals per day; SHS 92/93: eating 
fruits and vegetables at least once per day. 
e Percent of all deaths in this smoking category. 
f Percent of all cancer deaths in this smoking category.  
g Only women, h Only men, BMI= body mass index, SD= standard deviation. 
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Table 2: Hazard Ratios (HR) with 95% confidence intervals (CI) for different BMI and smoking 
categories resulting from the fully adjusted model. Sex-specific results can be found in 
Supplementary Table S3. 
Cancer site 
 
Deaths 
(n) 
 
Body Mass Index a Smoking 
b 
(cigarette equivalents per day) 
≥ 25 - < 30 ≥ 30 former light (<20) heavy (≥20) 
all sites 2,379 1.01  [0.92,1.10] 
1.15  
[1.01,1.32] 
1.31  
[1.16,1.47] 
1.37  
[1.22,1.53] 
2.32  
[2.04,2.63] 
lung 426 0.95  [0.77,1.17] 
0.80  
[0.57,1.14] 
2.29  
[1.64,3.20] 
3.11  
[2.26,4.26] 
9.86  
[7.29,13.33] 
colon or rectum 250 1.11  [0.84,1.46] 
1.30  
[0.87,1.95] 
1.13  
[0.80,1.58] 
0.99  
[0.69,1.42] 
0.87  
[0.53,1.45] 
UADT c 125 0.71  [0.48,1.05] 
0.78  
[0.42,1.43] 
1.84  
[1.03,3.29] 
2.62  
[1.53,4.49] 
5.45  
[3.18,9.34] 
blood 246 1.02  [0.77,1.35] 
1.13  
[0.74,1.74] 
1.14  
[0.80,1.62] 
1.00  
[0.70,1.43] 
1.16  
[0.74,1.81] 
pancreas 127 1.20  [0.81,1.78] 
1.60  
[0.93,2.75] 
1.46  
[0.89,2.40] 
1.46  
[0.89,2.39] 
1.84  
[1.01,3.37] 
bladder 85 0.62  [0.38,1.02] 
1.16  
[0.62,2.18] 
1.01  
[0.53,1.95] 
1.22  
[0.65,2.29] 
2.57  
[1.33,4.93] 
liver 81 1.28  [0.77,2.12] 
2.21  
[1.18,4.15] 
2.14  
[1.14,4.01] 
1.76  
[0.91,3.42] 
3.41  
[1.74,6.70] 
stomach 74 1.19  [0.72,1.98] 
1.45  
[0.71,2.95] 
1.23  
[0.66,2.27] 
0.60  
[0.27,1.34] 
1.34  
[0.62,2.91] 
female breast 201 1.16  [0.84,1.60] 
1.07  
[0.64,1.79] 
0.79  
[0.49,1.29] 
0.77  
[0.49,1.21] 
1.38  
[0.82,2.33] 
female genitals d 132 1.31  [0.88,1.95] 
1.88  
[1.10,3.20] 
1.21  
[0.69,2.12] 
1.48  
[0.92,2.36] 
1.16  
[0.52,2.58] 
Prostate 170 1.45  [1.03,2.04] 
1.54  
[0.93,2.55] 
1.12  
[0.76,1.66] 
1.38  
[0.93,2.05] 
0.68  
[0.35,1.29] 
remaining 462 0.89  [0.73,1.09] 
1.08  
[0.80,1.46] 
1.22  
[0.94,1.58] 
1.18  
[0.91,1.54] 
1.53  
[1.12,2.09] 
Models are adjusted for sex (where appropriate), age, survey, alcohol consumption, frequency of 
physical activity, civil status, years of education, nationality, and healthy diet. 
a Reference: BMI < 25 kg/m2 
b Reference: never smoking. One pipe or cigarillo correspondent to two and one cigar to four 
cigarette equivalents. 
c Cancer of upper Aero-digestive tract: malignant growth of lips, oropharynx, nasopharynx, piriform 
sinus, laryngopharynx, oesophagus, larynx 
d Cancer of female genitals: malignant growth of vulva, vagina, cervix uteri, corpus uteri, ovary, 
placenta 
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Figures 
 
Figure 1: Cumulative hazard ratios (HR) of body mass index (BMI) and smoking on selected cancer 
sites.  
 
Combined HRs resulting from the full model adjusted for sex (where appropriate), age, survey, 
alcohol consumption, frequency of physical activity, civil status, years of education, nationality, and 
healthy diet. Note: Y-Axis starts at HR=1. Exact figures with CIs for all cancer sites are shown in 
Supplementary Table S4. 
Reading example: Heavy smokers, that are obese (BMI ≥ 30 kg/m2), have a 2.9-fold risk to die of 
pancreatic cancer, compared to normal-weight (BMI < 25 kg/m2) never smokers. 
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Figure 2: Population attributable fractions (PAF) of smoking (ever, including former), BMI ≥ 25 kg/m2 
and both factors combined in percent. PAFs that are significantly greater than zero are marked by a 
filled circle. 
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Figure 2 
 
Depicted are the results from the full model adjusted for sex (where appropriate), age, survey, 
alcohol consumption, frequency of physical activity, civil status, years of education, nationality, and 
healthy diet. Exact results including 95% CIs are shown in Supplementary Table S5.  
Reading example: Of all pancreas cancer deaths, 12% (not significant), 19% (sign.) or 29% (sign.) 
are attributable to a BMI ≥ 25 kg/m2, ever smoking or both risk factors combined, respectively. 
